First-Line Anti-Egfr Agents (Panitumumab or Cetuximab) Plus Chemotherapy in Patients With Metastatic Colorectal Cancer: Onco-Colon Turkey Study Subgroup Analysis
dc.authorwosid | Alacacioglu, Ahmet/W-1557-2017 | |
dc.authorwosid | Sendur, Mehmet/H-7555-2014 | |
dc.authorwosid | Harputluoglu, Hakan/Abi-6451-2020 | |
dc.authorwosid | Cicin, Irfan/Aaq-5575-2020 | |
dc.authorwosid | Bilir, Cemil/A-2491-2017 | |
dc.authorwosid | Geredeli, Caglayan/Aan-4122-2020 | |
dc.contributor.author | Isikdogan, A. | |
dc.contributor.author | Turk, H. | |
dc.contributor.author | Bilir, C. | |
dc.contributor.author | Sendur, M. | |
dc.contributor.author | Karabulut, B. | |
dc.contributor.author | Artac, M. | |
dc.contributor.author | Yalcin, S. | |
dc.date.accessioned | 2025-05-10T17:37:00Z | |
dc.date.available | 2025-05-10T17:37:00Z | |
dc.date.issued | 2022 | |
dc.department | T.C. Van Yüzüncü Yıl Üniversitesi | en_US |
dc.department-temp | [Isikdogan, A.] Dicle Univ Hosp, Diyarbakir, Turkey; [Turk, H.] Bezmialem Vakif Univ Hosp, Istanbul, Turkey; [Bilir, C.] Sakarya Univ, Med Sch, Sakarya, Turkey; [Sendur, M.] Ankara Yildirim Beyazit Univ, Fac Med, Ankara, Turkey; [Sendur, M.] Ankara City Hosp, Ankara, Turkey; [Karabulut, B.] Ege Univ, Tulay Aktas Oncol Hosp, Izmir, Turkey; [Artac, M.] Necmettin Erbakan Univ, Meram Med Sch, Konya, Turkey; [Cicin, I.] Trakya Univ, Sch Med, Edirne, Turkey; [Geredeli, C.] SBU, Cemil Tascioglu Sehir Hosp, Istanbul, Turkey; [Alacacioglu, A.] Katip Celebi Univ, Ataturk Res & Training Hosp, Izmir, Turkey; [Kefeli, U.] Kocaeli Univ, Sch Med, Kocaeli, Turkey; [Harputluoglu, H.] Inonu Univ, Turgut Ozal Med Ctr, Malatya, Turkey; [Bozkurt, O.] Erciyes Univ, Sch Med, Kayseri, Turkey; [Cubukcu, E.] Uludag Univ Hosp, Bursa, Turkey; [Tural, D.] SBU, Bakirkoy Sadi Konuk Hosp, Istanbul, Turkey; [Sakin, A.] Yuzuncu Yil Univ Hosp, Istanbul Fatih, Turkey; [Cil, T.] SBU, Adana SUAM, Adana, Turkey; [Dane, F.] Marmara Univ, Istanbul, Turkey; [Cevik, D.] Amgen Turkey, Istanbul, Turkey; [Arslan, C.] Izmir Econ Univ, Medicalpk Hosp, Izmir, Turkey; [Karadurmus, N.] SBU, Gulhane Med Fac, Ankara, Turkey; [Gumus, M.] Istanbul Medeniyet Univ, Goztepe Prof Dr Suleyman Yalcin City Hosp, Istanbul, Turkey; [Yalcin, S.] Hacettepe Univ, Ankara, Turkey | en_US |
dc.description.sponsorship | Amgen | en_US |
dc.description.sponsorship | Amgen. | en_US |
dc.description.woscitationindex | Science Citation Index Expanded - Conference Proceedings Citation Index - Science | |
dc.identifier.doi | 10.1016/j.annonc.2022.04.180 | |
dc.identifier.endpage | S281 | en_US |
dc.identifier.issn | 0923-7534 | |
dc.identifier.issn | 1569-8041 | |
dc.identifier.scopusquality | Q1 | |
dc.identifier.startpage | S281 | en_US |
dc.identifier.uri | https://doi.org/10.1016/j.annonc.2022.04.180 | |
dc.identifier.uri | https://hdl.handle.net/20.500.14720/14241 | |
dc.identifier.volume | 33 | en_US |
dc.identifier.wos | WOS:000823826500103 | |
dc.identifier.wosquality | Q1 | |
dc.language.iso | en | en_US |
dc.publisher | Elsevier | en_US |
dc.relation.ispartof | ESMO 24th World Congress on Gastrointestinal Cancer -- JUN 29-JUL 02, 2022 -- Barcelona, SPAIN | en_US |
dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.title | First-Line Anti-Egfr Agents (Panitumumab or Cetuximab) Plus Chemotherapy in Patients With Metastatic Colorectal Cancer: Onco-Colon Turkey Study Subgroup Analysis | en_US |
dc.type | Conference Object | en_US |